Onychomycosis due to Ulocladium botrytis

Summary A case of disto‐lateral onychomycosis of the third toe of the right foot of a 45‐year‐old man is reported. The agent of infection was Ulocladium botrytis, a mycete not hitherto reported to infect humans. The patient underwent mycological examination consisting of direct microscope observatio...

Full description

Saved in:
Bibliographic Details
Published in:Mycoses 2004-08, Vol.47 (7), p.346-348
Main Authors: Romano, C., Maritati, E., Paccagnini, E., Massai, L.
Format: Article
Language:English
Subjects:
Ascomycota - isolation & purification
ciclopiroxolamine
Foot Dermatoses - diagnosis
Foot Dermatoses - microbiology
Humans
Male
onychomycosis
Onychomycosis - diagnosis
Onychomycosis - microbiology
Onychomykose
Ulocladium botrytis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary A case of disto‐lateral onychomycosis of the third toe of the right foot of a 45‐year‐old man is reported. The agent of infection was Ulocladium botrytis, a mycete not hitherto reported to infect humans. The patient underwent mycological examination consisting of direct microscope observation and culture of pathological material. Diagnosis was based on the macro‐ and microscopic characteristics of the colonies. Fragments of the latter were also examined by scanning electron microscope. Clinical and mycological recovery was achieved after 3 months of topical therapy with ciclopiroxolamine. Zusammenfassung Es wird über eine distolaterale Onychomykose am dritten Zeh des rechten Fußes bei einem 45‐jährigen Mann berichtet. Erreger war Ulocladium botrytis, von dem bisher Infektionen am Menschen nicht bekannt waren. Der Patient wurde mikroskopisch und kulturell auf Pilze untersucht. Zur Identifizierund dienten makro‐und mikroskopische Merkmale. Koloniematerial wurde auch raster‐elektronenmikroskopisch untersucht. Die klinische und mykologische Heilung wurde mit dreimonatiger topischer Ciclopiroxolamintherapie erreicht.
ISSN:0933-7407
1439-0507
DOI:10.1111/j.1439-0507.2004.00999.x